Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2022-02-14 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a quarterly financial results announcement for Arvee Laboratories (India) Limited, specifically an extract of standalone unaudited financial results for the quarter and nine months ended December 31, 2021. It includes key financial metrics such as total revenue, net profit before and after tax, comprehensive income, paid-up equity share capital, and earnings per share. The document is about quarterly financial performance and contains substantive financial data, not just a brief announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-02-14 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Arvee Laboratories (India) Limited to the National Stock Exchange of India dated 8th February 2022. It announces the outcome of a Board Meeting held on the same date, specifically the approval of unaudited financial results for the quarter and half year ended 31st December 2021. The document includes a limited review report from the statutory auditors and detailed unaudited financial results for the quarter and nine months ended December 31, 2021. The presence of detailed financial data and the nature of the results indicate this is a comprehensive interim financial report rather than a brief earnings release or an announcement of a report. The document is about quarterly and nine-month unaudited financial results, which fits the definition of an Interim / Quarterly Report (IR).
2022-02-08 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of content, this cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or empty filings.
2022-01-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (78 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous filings.
2021-12-29 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including revenue, expenses, profit/loss, and tax information for the quarter and half year ended September 30, 2021. It is titled 'STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON SEPTEMBER 30, 2021' and includes multiple financial line items and comparative periods. The presence of unaudited quarterly financial results with substantive financial data indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements rather than just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2021-11-12 English
Financial Result Updates
Regulatory Filings
2021-11-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.